Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,743 INR | -1.89% | +1.57% | +3.91% |
May. 14 | Transcript : Zydus Wellness Limited, Q4 2024 Earnings Call, May 14, 2024 | |
May. 14 | Zydus Wellness Sees Rise in Fiscal Q4 Consolidated Net Profit | MT |
Strengths
- The group's high margin levels account for strong profits.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- With an expected P/E ratio at 38.01 and 28.75 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 4.85 times its current sales, is high.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.91% | 1.36B | C+ | ||
-1.92% | 278B | A- | ||
-2.98% | 94.26B | C+ | ||
-3.24% | 43.45B | C+ | ||
+11.61% | 42.08B | B- | ||
+2.22% | 41.79B | B- | ||
+9.66% | 40.33B | B- | ||
-15.72% | 30.1B | B- | ||
-7.51% | 28.96B | A | ||
+15.11% | 25.85B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ZYDUSWELL Stock
- Ratings Zydus Wellness Limited